Foundation of BiosChile Ingeniería Genética S.A.
BiosChile establishes Austral Biologicals, a subsidiary in San Ramón, California, to sell products for biomedical research.
The company receives the V Centenario award in the small companies category, granted by the Ibero-American program in Science and Technology, which is given to the most innovative companies.
BiosChile launches its ELISA test for the detection of antibodies against Chagas disease that has been commercialized since then throughout Latin America. To this is added the development of reagents for blood typing and several diagnostic tests for infectious diseases, such as He-Py Test TM , for the detection of Helicobacter pylori in gastric biopsies, and RotaclonTM, a rapid test for the detection of Rotavirus, among others.
The first product for the detection of pathogens in salmon is launched. Since then, BiosChile has developed a complete line of tests to detect numerous bacteria and viruses that affect salmon, providing an important tool to the salmon industry.
BiosChile signs an agreement with the Spanish group CH- Werfen, which results in the establishment in Chile of BiosWerfen S.A., which will be in charge of distributing the diagnostic products manufactured by both parties.
Dr. Pablo Valenzuela, Chairman of the Board of GrupoBios, receives the National Award for Applied Sciences and Technology for his important contribution to the area.
Dr. Luis Burzio, Scientific Director of GrupoBios, receives the prestigious Pasteur Biotechnology Award AMSUD 2004, for the research project "A New Family of Non-Coding Mitochondrial RNAs as Targets for Diagnosis and Cancer Therapy".
BiosChile and BiosWerfen move to a new corporate building. The new headquarters is located in the city of Santiago and comprises an area of 20,000 m2 with 6,000 m2 of laboratories, warehouses, manufacturing facilities and administration offices.
BiosChile develops a recombinant vaccine against Piscirickettsia salmonis.
BiosChile and BiosWerfen merge into GrupoBios S.A.
Andes Biotechnologies is formed, a spinoff of our Cancer Research area.
GrupoBios, in partnership with Bioteccel, founded BiosCell, the first bank of expanded stem cells in the country.
GrupoBios sells its share of BiosCell and focuses on developing new business lines.